INS and Alzheimer disease: This study showed that Aβ infusion to the hippocampus attenuated insulin signaling in the hippocampus, increased neuroinflammation, and exacerbated systemic glucose intolerance and insulin resistance, resulting in an AD-like pathology in the animal model.